SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-031818
Filing Date
2022-12-13
Accepted
2022-12-13 16:32:29
Documents
56
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20221031.htm   iXBRL 10-Q 908026
2 EX-31.1 csbrq21031202210-qex311.htm EX-31.1 10886
3 EX-31.2 csbrq21031202210-qex312.htm EX-31.2 10986
4 EX-32.1 csbrq21031202210-qex321.htm EX-32.1 8025
  Complete submission text file 0001628280-22-031818.txt   4312567

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20221031.xsd EX-101.SCH 31437
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20221031_cal.xml EX-101.CAL 44664
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20221031_def.xml EX-101.DEF 124561
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20221031_lab.xml EX-101.LAB 396513
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20221031_pre.xml EX-101.PRE 242396
50 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20221031_htm.xml XML 682889
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 221460100
SIC: 2836 Biological Products, (No Diagnostic Substances)